Evaxion A/S (NASDAQ: EVAX) presented new preclinical data for its cytomegalovirus (CMV) vaccine program, EVX-V1, at the International Herpesvirus Workshop ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA